食用菌多糖的提取纯化及生物活性研究进展

食用菌多糖因具有抗氧化、免疫调节、抗肿瘤、降血糖、降血脂等生物活性而备受关注。食用菌多糖的结构影响其生物活性,具有(1→3)、(1→4)、(1→6)及混合糖苷键的β-D-葡聚糖是高活性食用菌多糖的结构特征之一,展现出提高抗氧化酶活性、促进分泌抗癌因子、刺激脾脏和胸腺细胞增殖等不同功能。酸碱、超声波及微波、Sevag法、树脂法、亲和层析等不同提取纯化方法会影响食用菌多糖得率,同时会改变食用菌多糖结构,影响其生物活性。详述食用菌多糖的提取纯化方法及其对结构与活性的影响,食用菌多糖的组成结构和构效关系,以及食用菌多糖在抗氧化、抗肿瘤、免疫调节、降血糖和降血脂等方面的功能、结构特征及生物活性,并提出了食用菌多糖形成的分子机制、多糖活性位点修饰、多糖代谢动力学等未来研究方向。     

南瓜多糖的单糖组成及其生理效应

南瓜多糖是南瓜中重要的活性成分,由葡萄糖、半乳糖、阿拉伯糖、葡萄糖醛酸等单糖组成,是一类主链上含有β-1,3糖苷键、侧链含有α-糖苷键的杂多糖。南瓜多糖具有降血糖、调理血脂、抑制肿瘤、抗氧化等生理作用。本文对南瓜多糖的化学组成和生理效应进行了综述,最后,对南瓜多糖的研究方向进行了展望。     

恩施绿茶茶多糖对糖尿病模型大鼠血糖的影响

目的:研究恩施绿茶茶多糖对糖尿病模型大鼠血糖的影响。方法:用四氧嘧啶(alloxan)建立糖尿病模型大鼠,行恩施绿茶茶多糖灌胃4周,观察糖尿病大鼠血糖(FBG)、胰岛素(INS)、肝葡萄糖激酶(GK)、血清中丙二醛(MDA)、超氧化物歧化酶(SOD)和谷胱甘肽过氧化物酶(GSH-Px)以及脾脏、胸腺系数的变化。结果:恩施绿茶茶多糖能明显降低糖尿病大鼠的FBG,增强GK、SOD和GSH-Px的活性,减少MDA的含量,升高脾脏、胸腺系数。结论:恩施绿茶茶多糖具有降血糖,抗氧化和增强机体免疫功能的作用。     

茶叶不同提取成分降血糖作用的研究与比较

目的:探讨茶多糖、茶多酚、茶色素对血糖的降低作用.方法:用链脲佐菌素(STZ)建立糖尿病小鼠模型.提取茶多糖,茶多酚,茶色素,作用于糖尿病小鼠.通过葡萄糖氧化酶法(GOD-POD)测定血糖含量,研究并比较各成分的降血糖作用.结果:茶多酚,茶色素具有明显的降血糖作用,茶多糖的降血糖作用不明显.结论:茶多糖,茶多酚,茶色素均具有降血糖的作用.     

桑叶多糖降血糖作用及其机制研究

大量研究与临床实践表明,中药多糖成分有着显著的降血糖、强化机体免疫力等效果,而这中药中也包括了桑叶,其多糖成分同样有着降血糖的效果。故文章通过文献分析法,对桑叶多糖成分的降血糖效果与作用机制作一综述性分析。     

小分子葡萄糖激酶激动剂

2 型糖尿病作为一种慢性代谢疾病,目前尚无理想的治疗药物。葡萄糖激酶能够迅速将葡萄糖磷酸化,在降低促使胰岛β 细胞释放胰岛素的葡萄糖调定点、调控肝葡萄糖代谢这2 个方面发挥着重要作用。小分子葡萄糖激酶激动剂因在降血糖方面的作用而有望成为新一代治疗2 型糖尿病的药物。以葡萄糖激酶为靶点的小分子化合物陆续进入临床试验阶段,但尚无相关药物获准上市。对近几年报道的小分子葡萄糖激酶激动剂进行综述。     

猴头菌丝多糖降血糖作用研究

目的:研究猴头菌丝多糖的降血糖作用。方法:以液体发酵生产的猴头菌丝体为原料,经热水浸提、浓缩、酒精沉淀获得菌丝粗多糖;以常规降糖药物格列本脲为阳性治疗对照,通过四氧嘧啶诱发小鼠糖尿病的预防试验,比较猴头菌丝多糖各剂量与格列本脲的降血糖效果。结果:猴头菌丝多糖得率为7.14%,粗多糖再经Sevage法去除蛋白质,获得猴头菌丝精多糖(HMP),得率为10.92%;猴头多糖高、中、低三个剂量均能有效的对抗四氧嘧啶诱发的高血糖;其中,高剂量的降血糖作用与格列本脲相比,差异极显著。结论:猴头菌丝多糖对四氧嘧啶型高血糖模型小鼠有降血糖作用,作用效果优于格列本脲,对糖尿病小鼠的胰腺具有一定的保护作用。     

几种茶多糖对糖尿病模型小鼠血糖的影响

目的：研究和对比白茶、绿茶和红茶粗制多糖（crude tea polysaccharides,CTPs）的降血糖效果及机理。方法：分别选取寿眉、龙井、白琳工夫作为白茶、绿茶和红茶的代表,制备粗多糖。以链脲佐菌素诱导小鼠糖尿病模型,二甲双胍作为阳性对照,研究粗制茶多糖对小鼠体重、空腹血糖、胰岛素抵抗指数、葡萄糖耐量和胰腺组织病变情况的影响,qPCR测定小鼠肝脏中相关基因表达水平。结果：CTPs均具有降血糖功效,白茶、绿茶、红茶多糖的空腹血糖下降率分别为47.0%、47.8%、36.7%;CTPs均可改善小鼠葡萄糖耐量,下调Foxo1、G6Pc、PEPCK和TXNIP基因的表达量。结论：本实验剂量条件下,研究所选粗制茶多糖提取物均具有降血糖效果,其中绿茶多糖作用最明显。     

灵芝多糖对3T3-L1胰岛素抵抗细胞模型PI-3K p85和GLUT4蛋白表达的影响

目的 研究灵芝多糖对3T3-L1胰岛素抵抗细胞模型PI-3K p85和GLUT4蛋白表达的影响,探讨灵芝多糖改善胰岛素抵抗的分子机制.方法 3T3-L1前脂肪细胞经1-甲基-3-异丁基-黄嘌呤、地塞米松、胰岛素诱导分化成3T3-L1脂肪细胞,以葡萄糖氧化酶法测定培养液中残余的葡萄糖含量.比较二甲双胍组,检测培养液中葡萄糖含量及PI-3K p85和GLUT4蛋白表达变化.结果 地塞米松联合胰岛素诱导3T3-L1脂肪细胞产生胰岛素抵抗,细胞对葡萄糖的摄取量减少.灵芝多糖可改善3T3-L1脂肪细胞胰岛素抵抗.胰岛素抵抗细胞的PI-3K p85和GLUT4蛋白表达明显减少;应用灵芝多糖后,相关蛋白表达增加.结论 灵芝多糖通过提高PI-3K p85和GLUT4蛋白的表达,参与胰岛素抵抗状态下3T3-L1细胞的葡萄糖代谢.     

食用菌多糖的开发与利用

多糖是一切生命机体必不可少的成分,具有多方面的生物活性,是一类非特异性免疫增强剂,能提高机体免疫功能,增强抗病能力。由于食用菌在人类医疗保健领域被广泛采用,并产生显著效果,因而对食用菌多糖的研究日益受到重视。大量的研究证实,食用菌具强壮、滋补、抗癌等作用与含有多糖密切相关。一、食用菌多糖的生物活性1、香菇多糖(LNT) 通过增强机体免疫力或作为干扰素诱生剂达到抗肿     

Insulin secretion in the hibernating edible dormouse (Glis glis): in vivo and in vitro studies

Plasma glucose and insulin have been studied during lethargy and spontaneous arousal of hibernating edible dormouse. During lethargy blood glucose was low while plasma insulin remained at the same level as in other seasons. Plasma glucose and insulin did not fluctuate along the phase of lethargy. During spontaneous arousal plasma insulin rose strongly from the 17 degrees C stage, reaching the higher values at 26 degrees C while blood glucose was only 85 mg/100 ml, then decreased at 37 degrees C. The effect of glucose and temperature on insulin secretion was studied using perfused pancreas preparation from hibernating edible dormice. During the rewarming of the edible dormouse pancreas the insulin release did not occur in response to the absolute extracellular glucose level but occurred in response to a B cell membrane phenomenon which was dependent on the changing rate of glucose level. The effect of glucose and temperature on insulin secretion from perfused pancreas was compared between edible dormouse and homeotherm permanent, the rat. The B cell response to glucose of the dormouse pancreas increased up to 15 degrees C whereas that of the rat only from 25 degrees C. The dormouse insulin secretion reached a peak value at the 30 degrees C of temperature, whereas that of the rat progressively increased until 37 degrees C. These results showed that some biochemical adjustment or process of acclimatization took place in the B cells of the hibernators.     

胰岛素抵抗细胞与大鼠模型的建立及其应用

目的探讨胰岛素抵抗模型的建立方法和二苯乙烯对血糖的调节作用。方法①给予Wistar大鼠自制脂肪乳建立胰岛素抵抗动物模型。②给予HepG2细胞胰岛素,建立胰岛素抵抗（HepG2/IR）细胞模型。③分别给予模型大鼠和HepG2/IR细胞二苯乙烯,观察二苯乙烯对血糖的调节作用。结果给予脂肪乳后,大鼠的血糖和TG、TC、LDL、HDL分别升高了72.87%和16.21%、139.93%、56.93%、18.32%,与建模前比,差异有显著性（P〈0.01）;给予二苯乙烯,模型组动物血糖和血脂水平比给药前明显降低（P〈0.05~0.01）;HepG2/IR葡萄糖消耗量比对照组（HepG2）明显增加。结论给予Wistar大鼠自制脂肪乳或给予HepG2细胞胰岛素,可建立胰岛素抵抗模型;二苯乙烯具有降低模型动物血糖和血脂、增加HepG2/IR葡萄糖消耗量的作用。     

Effectiveness of hypoglycemic agents in guinea pigs exposed to mixed gamma-neutron radiations

The effect of 200, 1000, and 5000 rads of mixed gamma-neutron radiations on total blood reducing sugar and blood glucose levels in guinea pigs was investigated 2 and 24 hours, and 9, 22, and 60 days postirradiation. In addition, the effectiveness of insulin and tolbutamide in these animals was evaluated before and after irradiation. Glucose increased to a lesser degree and later than did the nonglucose fraction of the blood sugar. Insulin and tolbutamide were at least as effective in irradiated animals as in unirradiated ones except after 5000 rads, when tolbutamide was significantly less effective. These results suggest that: (1) insufficient insulin is released by the pancreas in response to elevated blood sugar levels following irradiation; (2) the pancreas does produce insulin at these times and is able to release it in response to tolbutamide; and (3) a decrease in insulin production occurs following supralethal doses of radiation.     

胰岛β细胞"质"、"量"的辩证关系——"质"的三要素

高血糖是糖尿病典型的病理特征,血糖的波动是决定糖尿病患者是否出现并发症的重要因素,而由胰岛β细胞合成分泌的胰岛素,是体内唯一可以降低血糖的多肽类激素.胰岛β细胞"质"与"量"决定着体内胰岛素分泌情况和血糖的调控.围绕"促进β细胞损伤修复,提升胰岛β细胞质量是治疗糖尿病的核心"之理念,提出构成胰岛β细胞"质"的三要素:细胞结构、"真""假"胰岛素和胰岛素调节型分泌.旨在为β细胞质量评价和糖尿病机制研究提供一定的理论参考.     

Oral Glucose Tolerance and Related Factors in a Normal Population Sample—I. Blood Sugar,Plasma Insulin,Glyceride, and Cholesterol Measurements and the Effects of Age and Sex

Oral glucose tolerance tests were performed on 220 people, a representative sample of the employees of a large pharmaceutical company. Blood sugar and plasma immunoreactive insulin levels were measured on each sample of venous blood obtained before and at half-hourly intervals for two hours after 50 g. of glucose by mouth; plasma cholesterol and glycerides were measured on the fasting sample only.Women had higher mean insulin levels throughout the test, though their mean blood sugar levels were higher only at 90 and 120 minutes. In both sexes there were positive correlations between age and the levels of blood sugar, plasma cholesterol, and plasma glycerides. Though the levels of glucose rose with age, those of insulin did not.     

Blood glucose and insulin levels in thymectomized rats.

The rise of blood glucose level under sugar load was much greater in thymectomized than in normal rats, whereas the insulin level remained practically unchanged. This suggests that the rise of blood sugar level is due to two factors, one being the accumulation in blood of a substance, corresponding to the blood glucose level stimulator stored in the thymus, the other the simultaneous inhibition of insulin production, or of insulin transport, into blood.     

持续皮下输注赖脯胰岛素治疗老年非初诊2型糖尿病患者临床观察

目的：观察比较持续皮下输注赖脯胰岛素与常规注射预混赖脯胰岛素对老年非初诊2型糖尿病患者的疗效与安全性。方法：将58例老年2型糖尿病患者随机分为观察组（29例）与对照组（29例）,观察组用赖脯胰岛素经胰岛素泵持续皮下输注（CSI-I）,对照组用精蛋白锌重组赖脯胰岛素25注射液,2次／d,常规皮下注射。两组患者均给予糖尿病教育、饮食控制及适量运动,共治疗2周。比较治疗前后两组患者的血糖、胰岛素用量、血糖达标时间以及低血糖发生率。结果：治疗后两组患者空腹血糖、餐后血糖均较治疗前下降（P〈0．05）,观察组血糖达标时间、胰岛素用量均明显低于对照组（P〈0．05）。两组低血糖发生率无明显差异。结论：持续皮下输注赖脯胰岛素具有较好的疗效与安全性,是控制老年非初诊2型糖尿病患者较佳的方法。     

Failure of exogenous insulin to inhibit insulin secretion in man

In order to explore whether or not the negative feedback mechanism of insulin per se on insulin secretion exists in man, changes in plasma C-peptide immunoreactivity (CPR), as an index of pancreatic B cells secretory function, were studied in 6 nonobese healthy volunteers in the presence of high circulating levels of exogenous insulin. 10% glucose was infused concurrently so as to maintain blood sugar at the basal level. The insulin-glucose infusion was maintained for 120 minutes, achieving mean plasma levels of 140-180 mu1/ml. After this period, the insulin infusion was continued at the same rate for an additional 10 minutes while the glucose was omitted. Despite the elevated level of circulating insulin, no significant change in plasma CPR concentration was observed so long as the blood sugar was maintained at the basal levels. Following cessation of the glucose infusion, the plasma CPR levels declined with a decrease in blood sugar level. Under the conditions of the present study, no inhibitory effect of exogenous insulin on the secretory function of the B cells was noticed.     

化学修饰提高胰岛素口服降血糖作用的研究

本文探索了用小分子化合物对胰岛素进行化学修饰,以增加口服降血糖的可能性.制备了乙酰胰岛素、琥珀酰胰岛素和半乳糖酰胰岛素.这些胰岛素不仅较好地保持了天然胰岛素的活性,而且其口服降血糖作用也较天然胰岛素明显增加,其中琥珀酰胰岛素是天然胰岛素的口服降血糖作用的二倍以上.这为口服或肛门给药的胰岛素新剂型的研制提供了科学依据.     

Diurnal Variation in Response to Intravenous Glucose

Intravenous glucose tolerance tests (25 g) were performed in the morning and afternoon on 13 apparently normal persons. The individual K values (rate of decline of blood sugar) were all higher in the morning tests, and the mean values were significantly higher in the morning. Fasting blood sugar levels were slightly lower in the afternoon. There was no difference between the fasting morning and afternoon plasma insulin levels, but the levels after glucose were lower in the afternoon. Growth hormone levels were low at all times in non-apprehensive subjects and unaffected by glucose. The results suggest that the impaired afternoon intravenous glucose tolerance, like oral glucose tolerance, is associated with impaired insulin release and insulin resistance.